Effects of Chronic Lymphocytic Leukemia on the Development and Progression of Malignant Melanoma

• Published in: Dermatologic surgery Vol. 36; no. 3; pp. 368 - 376
• Main Authors: BREWER, JERRY D., CHRISTENSON, LESLIE J., WEENIG, ROGER H., WEAVER, AMY L.
• Format: Journal Article
• Language: English
• Published: Malden, USA Blackwell Publishing Inc 01.03.2010; Wiley
• Subjects: Adult; Aged; Aged, 80 and over; Biological and medical sciences; Comorbidity; Dermatology; Disease Progression; Disease-Free Survival; Female; Hematologic and hematopoietic diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology; Leukemia, Lymphocytic, Chronic, B-Cell - mortality; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Male; Medical sciences; Melanoma - epidemiology; Melanoma - mortality; Melanoma - pathology; Middle Aged; Neoplasm Recurrence, Local - pathology; Retrospective Studies; Skin Neoplasms - epidemiology; Skin Neoplasms - mortality; Skin Neoplasms - pathology; Skin plastic surgery; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Tumors of the skin and soft tissue. Premalignant lesions; Chronic lymphocytic leukemia; Prognosis; Treatment; Dermatology; Lymphoproliferative syndrome; Surgery; Malignant melanoma; Evolution; Malignant hemopathy; Malignant tumor; Cancer
• ISSN: 1076-0512; 1524-4725
• DOI: 10.1111/j.1524-4725.2009.01447.x

BACKGROUND An association exists between chronic lymphocytic leukemia and malignant melanoma. OBJECTIVES To study the clinical behavior of malignant melanoma in patients with chronic lymphocytic leukemia. METHODS A retrospective chart review was conducted of patients with chronic lymphocytic leukemia and malignant melanoma. RESULTS Sixty‐nine patients had malignant melanoma and chronic lymphocytic leukemia. The recurrence‐free and metastasis‐free survival rates at 2, 5, and 10 years were 93.4% and 89.1%, 83.8% and 93.4%, and 87.4% and 82.1%, respectively. No significant difference was observed in age‐ and sex‐adjusted mortality rates between patients with chronic lymphocytic leukemia diagnosed before malignant melanoma and those with chronic lymphocytic leukemia diagnosed after malignant melanoma. LIMITATIONS Retrospective study and small patient population. CONCLUSION Patients with malignant melanoma and chronic lymphocytic leukemia were not shown to have worse survival rates than those with stage IA, IB, and IIA disease. Further research and prospective study are needed. The authors have indicated no significant interest with commercial supporters.